These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1097512)

  • 1. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL; Koene RA; Kamp GJ; Gerlag PG; Wijdeveld PA
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
    Capel PJ; Tamboer WP; de Waal RM; Jansen JL; Koene RA
    J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N; Bach FH
    J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
    Sachs DH; Winn HJ; Russell PS
    J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.
    Lems SP; Jacobs CW; Capel PJ; Koene RA
    J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.
    Lems SP; Tax WJ; Capel PJ; Koene RA
    J Immunol; 1983 Jul; 131(1):86-91. PubMed ID: 6345667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
    Staines NA; Guy K; Davies DA
    Eur J Immunol; 1975 Nov; 5(11):782-9. PubMed ID: 802473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new in vitro test evaluating anti-lymphocyte serum potency.
    Bach JF; Dardenne M; Dormont J; Antoine B
    Transplant Proc; 1969 Mar; 1(1):403-7. PubMed ID: 4944250
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
    Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
    J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
    [No Abstract]   [Full Text] [Related]  

  • 14. Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice.
    Fekete B; Petrányi G; Szegedi G; Szabó G
    Haematologia (Budap); 1971; 5(4):419-23. PubMed ID: 4948255
    [No Abstract]   [Full Text] [Related]  

  • 15. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation.
    Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression.
    Murray-Segal L; Gock H; Cowan PJ; d'Apice AJ
    Xenotransplantation; 2008 Feb; 15(1):20-6. PubMed ID: 18333910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 20. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
    Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
    Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.